Details of the Drug | DrugMAP

General Information of Drug (ID: DME2AZG)

Drug Name	US10150740, Example 1
Synonyms	SCHEMBL18425452; US10150740, Example 1; BDBM307505
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)			302.28
	Logarithm of the Partition Coefficient (xlogp)			-0.8
	Rotatable Bond Count (rotbonds)			3
	Hydrogen Bond Donor Count (hbonddonor)			2
	Hydrogen Bond Acceptor Count (hbondacc)			7
Chemical Identifiers	Formula C15H14N2O5 IUPAC Name 9,10-dimethoxy-2-oxo-6,7-dihydropyrido[2,1-a]phthalazine-3-carboxylic acid Canonical SMILES COC1=C(C=C2C(=C1)CNN3C2=CC(=O)C(=C3)C(=O)O)OC InChI InChI=1S/C15H14N2O5/c1-21-13-3-8-6-16-17-7-10(15(19)20)12(18)5-11(17)9(8)4-14(13)22-2/h3-5,7,16H,6H2,1-2H3,(H,19,20) InChIKey BPBHVSAWZGGVPZ-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 126508802 TTD ID D0PG7W

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hepatitis C virus Core protein messenger RNA (HCV Core mRNA)	TTQFZWR	POLG_HCV1	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection. US10150740.